Investors should focus mainly on the adjusted numbers for operating and net income, which exclude one-time items.

Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

Argan's strong growth faces sustainability challenges amid high valuation risks and competition. Read here for an analysis of ...

The Oregon Ducks have a lot to prove entering the 2025 college football season, looking to show that their Big Ten ...

The first thing to understand about Dollar General's rise is that it's only a partial rebound from a much steeper decline. The stock is still down roughly 57% from its 2022 high-water mark. That's one ...